Point72 Asset Management’s Idexx Laboratories IDXX Stock Holding History

Point72 Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,400	Closed	-$2.81M	–	4019
2025 Q3	$2.81M	Hold	4,400	–	–	﹤0.01%	1306
2025 Q2	$2.36M	Hold	4,400	–	–	﹤0.01%	1233
2025 Q1	$1.85M	Buy	4,400 +500	+13%	+$217K	﹤0.01%	1268
2024 Q4	$1.61M	Buy	+3,900	New	+$1.71M	﹤0.01%	1319
2024 Q3	–	Sell	-3,100	Closed	-$1.51M	–	2157
2024 Q2	$1.51M	Buy	+3,100	New	+$1.56M	﹤0.01%	1172
2022 Q3	–	Sell	-18,000	Closed	-$6.31M	–	1537
2022 Q2	$6.31M	Buy	+18,000	New	+$7.34M	0.03%	641

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's IDXX Position: Q1 2026 in Review

Point72 Asset Management increased its Idexx Laboratories (IDXX) stake by 1,054% in Q1 2026, buying an estimated $75.7M and bringing the position to 129,284 shares worth $72.6M. The position accounts for 0.09% of the portfolio, ranked #248.

Point72 Asset Management first reported a position in IDXX in Q1 2015 and has held it in 16 quarters since. The position peaked at $78M in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Point72 Asset Management held 129,284 shares of Idexx Laboratories worth $72.6M as of Q1 2026.
Point72 Asset Management bought 118,080 Idexx Laboratories shares in Q1 2026, an estimated $75.7M.
Idexx Laboratories made up 0.09% of Point72 Asset Management's portfolio in Q1 2026, its #248 holding.
Point72 Asset Management first reported a position in Idexx Laboratories in Q1 2015 and has held it in 16 quarters since.
Point72 Asset Management's Idexx Laboratories position peaked at $78M in Q4 2023.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.